0:00Hey, guys. Welcome to the podcast. I have a special guest today, Michael Khan. Guys, so I've known Michael for a while. We actually did a the first ever live episode that I've ever done was panel. It was at an event in Philly, and Michael was on the panel. So he is not a new guest, but this is the first time he and I are just doing a studio episode. So, Michael, welcome to the show. How are doing, buddy? Tom, it's great to be here.
0:31I am doing fantastic. It's a holiday week. We're recording this right before Thanksgiving. Weather's great. I'm super stoked. Yeah. And we are gonna talk about so Michael came up with the title, links or patties, how the sausage is made in medical affairs. So we're gonna get into an awesome conversation about decision making and behind the scenes stuff in medical affairs. Before we do that, I wanna, first of all, wish everyone a happy Thanksgiving and holiday
1:02season. This might actually come out after Thanksgiving. So I wanna wish you guys all a happy holiday season. As always, for those of you who are job seekers, definitely reach out if I can be of any help to you. I'm a recruiter by day, podcaster by night. I have to mention that because a lot of people are like, hey, I just thought you had a podcast. I didn't know what you did for a living. And also consider buying my book, Job Search Mastery, How to Win Your Dream Job if you're on the market. The only reason I say this, not a shameless plug, but there's a lot of people on the market
1:33right now and they're looking for help. So I put everything that I know into that resource. It's available on Amazon. So but before we get into even talking about this topic, Michael, do you wanna do an introduction? Tell everybody who you are, where you're from, all that good stuff. I would love to. Hello, world. I'm Michael Kahn. I've been in the pharmaceutical industry for longer than I care to admit. My original background is medical communications, particularly scientific publications coming out of Northwestern where I did my undergrad in journalism.
2:07Started my MBA about ten years ago and through that facilitated a transition into operations and then into medical excellence. I've been with been with Shire. I've been with Spark Therapeutics. I am currently a free agent looking for my next opportunity. And so it's it's great to be here, Tom. Thank you for having me. Awesome, man. Awesome. It's gonna be a great conversation. Let's start I'd love to start with the with the title. You came up with the title links or Patty. So, like, how how does that relate to medical affairs and decision making and what goes on
2:40behind the scenes? Right. So, you know, the expression, let's find out how the sausage is made and go, you know, we kinda wanna you know, don't go behind the scenes. Just want to consume it. I think we all would benefit at every level from, you know, transparency in a window into decision making that that others do that inevitably have an effect on us as stakeholders in in any realm. Sure. Right? And so I you know, of course, I was trying to be somewhat clever, with the title about how
3:12sausage gets, made, but I do believe, and and we'll talk about this, that different decision making styles result in different decisions, I e, links or patties. And and so understanding, you know, if you're you know, for the purposes of this audience, an MSL or an aspiring MSL or even, from another pocket of pharma, just understanding how leadership may go about making decisions, shed some light, into what is happening at your
3:43organization, how it's happening, and how it's communicated, and and the effects downstream of all that. Yeah. Well, let's let's jump into it. Because I think what happens is in medical affairs, we kinda see the the polished results. We see what, you know, what what we're what we're supposed to see. But what actually does go into making the sausage into the decision making processes and what, you know, the behind the scenes?
4:15What actually does go into it? Yeah. That that's the $100,000 question. Right? And and I think it's important to start with the observation that at the higher levels of any organization, the decision making and the the careful consideration of whether something is an opportunity or a problem or a question, it becomes more complex. And the proportion of the day spent on working through problems and essentially decision making becomes greater the higher up you go. You know? The CEO setting a vision, talking with his or her direct reports, they're making decisions
4:49all day that that impact the rest of the organization. And so the answer to that question is a long one, but I think it starts with the context of the decision that's being made and the style of the organization. Is it small? Is it large? Is it a start up? Are there lots of layers? What industry are you in? Who are the stakeholders? To your point about being polished, complicated decisions that have a lot of consequences, things like starting or stopping development of an asset, you know, massive organizational
5:26changes, restructuring, you know, those those really challenging complex decisions that have a lot of effects on on stakeholders and a lot of other effects. You push one button, another one comes up. Those those decisions often come with a communication plan attached to them, and that's why they may seem polished and sometimes if, you know, unfortunately, overly so a little bit rehearsed. Mhmm. But it's but but I also think that when you have authentic relationships one on one with
5:57your with your leaders, you can get sometimes when it's appropriate beyond the the communication plan and the specific talking points. And, hopefully, you know, the real reasoning is reflected in those communication plans. We we hope certainly that leadership isn't misleading teams and people when it when it's making decision. But I think the the polish comes from an associated communication plan. Here's the decision, but here's the rationale that we intend to communicate behind it. The better a group, the better better the better a team does with that, you know, often,
6:31the more acceptance a decision can can result in. There's also in from my experience, varying degrees of how good certain organizations are at making these decisions, who's making the decisions, and how effectively they're being implemented and or how long it takes to make. There's just so much nuance to it. And it's not always just the size of the company.
7:02Sometimes it's just the leadership itself, like, as, you know, who's making the strategic decisions? Who's doing the tactical decisions? Or or is it the same? And how is it getting implemented? And how is it being successful? So the polish that we see sometimes is the result of maybe a much longer process or a much more messy process Mhmm. Than organizations that have it together. So I think what I'm left with is where do you see some of the biggest disconnect between how
7:37decisions should be made versus how decisions are made? That's a great question. If I think about that, you know, I think the first thing I think of is our organizations generally broadly succeeding in their decision making, and that that probably varies. Mhmm. It certainly you know, it varies in in my experience, but I I've been fortunate, you know, mostly in my career to have been working under leadership teams that are careful and
8:12reflective about it. Your point is very well taken that challenging large scale decisions, the ones that turn messy, often take a while, sometimes months, maybe a year in the case of, you know, completely for example, completely carving up a company and separating separating it into units. You know, those those decisions are typically not made impulsively. So how should a decision be made depends on the nature of the problem or the issue. Some decisions probably require just one person going, this is the way we should do it.
8:44Others, more complex, getting the right people in the room and having the conversations, and I think having time to reflect on it. Now that perspective is definitely informed by my experience in pharma. But if you change the lens entirely let, you know, let me talk about a start up in in check, right, that maybe is launching fast. Let's say they're, you know, trying to maximize the value of an IPO. Have you heard the team have you heard the term blitzscaling? Right? Going from very little to, you know, massive productions.
9:16It's very fast decision making. Mhmm. You know, try something. If it doesn't work, pivot fast, but we're going to grow, grow, grow, grow, grow. That's a very different decision making style, and it probably contributes to the chaotic feel of some of those organizations. But that's probably culturally appropriate, and it's probably organizationally appropriate for for for that lens. So there's more than one way to, quote, unquote, make the sausage, and and so much of it depends on, you know, the the size of the organization, the life cycle of the organization. Even a large organization that is newer, that is trying to get to market and big competitors
9:50maybe more nimble in its decision making because they need to be more nimble in its execution. Whereas a larger, much more established you know, if I'm thinking about pharma, if I'm thinking about companies that have been around fifty, seventy five, a hundred years, there's a long going culture that evolves more slowly. Right? And and so the decision making is likely to be probably more calculated, more more longer term thinking because, you know, the the time for rapid growth is is long past.
10:21You know, one of the first lessons I learned in pharma so before I became a recruiter and have you know, I've been in this business almost twenty five years. Before that, I spent ten years as a rep and I was working in big pharma. And one of the first lessons I learned is that nothing happens quickly in pharma. Even some of the smaller organizations. Just things just take time. It's like turning the Titanic. So and in my experience, I think a lot of that has to do with silos.
10:54So you have medical, clinical, commercial, regulatory. You have all the different groups. Operating in silos, how much of an impact does that have on the decision making process and the speed at which decisions are made? I believe, and this is my opinion only, the best decision makings making processes at that scale get all the relevant functions in the room and maybe plus a few, to have honest
11:25conversations about how certain decisions are going to affect different stakeholders in the company, and let's not forget external to the company, especially patients. One of the reasons I think the decision making takes so long in this industry, I I believe that by and far, the vast majority of pharma companies are good, respectable, quality players. And I believe the bad apples are few and far between, and most companies by far want to do the right thing by by their stakeholders, particularly patients.
11:57To do that when making large scale decisions takes time because these are not simple problems. They are they are often challenging, problems that affect multiple stakeholders, and therefore, functions are involved. And I think that's a challenge, for some people if particularly and I I'm definitely guilty of this earlier in my career coming up through medical and not having a lot of exposure to different functions, thinking to myself, well, you know, I don't understand this decision
12:28because it it just torpedoes the medical affairs plan. But what I didn't have awareness of was how does it impact the other functions and the other stakeholders? How does it impact patients? Is it financially sustainable? Right? Or would it would it kill the company? So there are lots of different variables beyond, in that case, my lens into medical, and it's the job ultimately of leadership to be able to assess those different stakeholders, those different functions, and make the decision, that supports the company and its
13:00mission, ideally, the best. And sometimes that's not the best decision for an individual stakeholder or an individual function. And I think that's where challenging communication can come in from leadership level, and that's where some of the frustrations can come in from functional contributors and leaders. Can you share examples of how maybe you've seen collaboration amongst these silos have led to kinda breaking through this Mhmm.
13:32Glut of of poor not poor decision, but maybe the glut of time it takes to make decisions and move things further and faster. Mhmm. I will preface this, and this applies to the Tom, you know what's coming. I'll preface this, and this applies to the the the entire podcast by saying these observations are are strictly my own. They don't reflect any previous employer or any future employer. Certainly hope that's in the cards.
14:03Right? So examples. I won't be specific, but, a common organizational model in pharma is the asset team. It has different names. It has different acronyms. But what we're talking about, whether we're talking about a drug, a medicine, a therapy that's in development, I e an asset, or is already launched, bringing a group together around that asset, and I'll I'll use just for the purposes of example, a launched marketed asset.
14:34Right? You're gonna have commercial. They're probably leading the asset team. You're gonna have medical. You may have regulatory if there are additional indications coming in. You'll have pharmacovigilance. You'll have probably finance. You'll have sales. And so a lot of different players at the table that are going to be frontline in they're gonna be the first to know when challenges to the asset that require thoughtful decision making
15:04come about. Mhmm. And if those decisions can't be resolved in that asset team or the asset team or the question is so big that the asset team isn't empowered to make that decision, then they have to escalate it. But the best teams bring together teams cross functionally in an asset team, and that's how they break down the silos. There's already a constituted group of people who are working together and representing their functions for the good of the asset, for the good of the enterprise. Right? And so when it comes to a difficult decision that's challenging, they will escalate it, but
15:37there's also a process for that. There's a presentation. There's thought put into the different perspectives, and it's raised probably to an executive level committee. This all sounds very formal, but I think it's a helpful window, particularly for field medical members who might be newer to industry who haven't been exposed to, how things typically work, in the home office. That asset team cross functionally is working together. They will see things. They will raise issues when need be, and and then probably one or more meetings will take
16:10place and and thought given to all the different perspectives and questions and challenges that that that that's raised. So the asset team model is is I won't say it's universal, but it it's been fairly standard everywhere I've been because you need all of those views and expertise at the table when when a group is when a group or an enterprise is challenged with an issue. Yeah. Alright. So let's unpack this a little bit. So you got a great leadership team.
16:41You have silos being broken down. You have collaboration, and silos are broken down. You have an asset team, like you just mentioned, and Mhmm. There's there's strategic plans that are happening, and things are moving along. How big a part do internal politics come into play in org I'm not saying every organization, some organizations. Just, when it comes to this piece of Mhmm. You know, decision making and forward progress.
17:13Mhmm. It can, and I think this is very organization dependent. I will say this. The best leaders I have worked with, and and there have been plenty who who who do this, are well aware of the internal politics. And people mean different things, by the way, about internal politics. I define it as a construct of the individual relationships and values and commitments that that one person might have to another that essentially create potentially a competing
17:45value against that for the enterprise. There are other ways to to to to to label it. That that's how I think about it. So a series of of relationships that brings up issues that are not necessarily central to the enterprise's mission. The best leaders are very aware that internal politics are there, and they can put them aside for the betterment of the enterprise saying this is the best decision for the patient, for the investor, for the enterprise, for long term sustainability.
18:16Whatever it is, they're looking for some final best interest, not necessarily, well, Tom, this works for you. I mean, you and I are gonna go into a cigar a smoke filled room, and we're we're gonna decide that this is the way to do it. We're just gonna roll it out. I think I haven't seen that, really. I'm I'm I'm sure it happens. I personally haven't seen it in in my experience. I will make one observation about those silos and functions in smaller companies. If at companies that might have fewer than 100 people and are driving toward approval of a
18:50very first asset, you might not the entire company might be the team. And so those are situations where the CEO, the CFO, other individuals might be very involved more in the day to day decision making than at larger organizations. That is by no means a criticism. Their involvement is critical to the success of the company, and they need to be there. So if I'm talking to, let's say, a publications leader, and they're wondering, why is the CEO,
19:24like, reviewing a manuscript? It's because the stakes are pretty high, but it's also incumbent upon that publications leader to appropriately, work with those senior leaders and explain the guardrails to do that, compliantly, but recognize that the CEO ultimately has the enterprise's best interests in mind. Yep. Sometimes some education is is needed there. But my point is that it varies in who is at the table varies when we're talking about different
19:55sizes of organization. I agree Yeah. Go ahead. With that, I agree that in this situation, the size of the company matters, but also how medical affairs centric is the organization. I've seen some organizations that are so commercially driven Mhmm. That medical affairs is fighting such an uphill battle to be heard that that becomes part of
20:27the stalemate, part of the slowdown of the process and the bottleneck of just kinda moving things forward. Whether it's just decision making on, you know, implementation of initiatives, hiring, building, growing, expanding, whatever. That's a piece of it that I see Mhmm. As and on my side of the equation as a a company that builds out medical affairs teams. That happens.
20:57Right? And and different companies have different cultures and different this is where politics, plays in a little bit. I think about strong medical affairs departments. And in addition to having extremely strong strategic leaders and tactical functional leaders, you know, they they block and tackle well. Right? You know, their med info systems are great. Their publications, plans are excellent. Everything's around a strategy. That's table stakes. The strongest medical affairs organizations that truly have a seat at the table are the
21:34ones whose leaders are, for lack of a better word, charismatic. They but they carry influence. They have that credibility because they deliver to the organization. Insights are great at this. We've all talked about insights being the currency of medical affairs. And if a medical affairs leader at that cross functional table can bring in insights, often, raises the bar, particularly with commercial to have influence at that decision making level. Organizations vary, but organizations like organizations like MAPS Mhmm.
22:08You know, which exists for, you know, the development of medical affairs professionals by definition, they are extremely engaged in developing medical affairs professionals' influence skills. There's storytelling skills beyond the data, you know, at the at the corporate level, the business domain of of which I'm on, and the leadership domain. Both of those domains are working on on many activities to to raise the level that medical affairs can influence at the leadership level.
22:41And I think we're starting to see, generally, in in the industry, medical affairs leadership, being a cut above, and really having that influence. So I I certainly have seen what you're talking about. I am optimistic and confident that that needle is moving to where medical affairs, is becoming an equal player at the table and valued for for what they bring, which is unique in the organization? It's gotten a lot better. I mean, it's the you know, we always you hear this in all the conferences about the value of
23:15the value proposition of medical affairs. Yeah. I mean, it's just in the past twenty five years, the needle has moved so far, and it's a much you know, the value has been accepted wide more widely. There's still that battle that happens and that tug of war that's going on with with commercial to a certain extent. Mhmm. But when it comes I'm gonna go back to hiring because, obviously, that's near and dear to me. Hiring and building out teams.
23:46Mhmm. What key factors should leaders prioritize when build when in when in their building mode? Fit. Number one, two, and three on my list. And when when I'm hiring for for my team Mhmm. You know, there's a job description, and there's a set of technical skills. Again, that's that's table stakes. I want to bring in somebody who is going to work extremely well with the team that's
24:18already there and perhaps make them better. And that that's how I define fit. K. And I've and I've heard it you know, the best leaders I've I've I've heard that from too. And I think that's where the panel interview really shines because individuals, on a given leadership team can then come back and debrief on a candidate and start to talk about, you know, the decision, whether to move forward with somebody, comes down to, in my experience,
24:52less about the skills than do do they fit? Can we see this person working here? Are they going to add to us? Are they gonna make us better? Do they fill a gap? Is it potentially redundant? For aspiring MSLs in particular, I think, you know, beyond being able to credibly and compellingly communicate data, having one or two particularly special skills to add to the team can really, in some cases, improve fit, whether that's technology.
25:24You know? Can you code? Can you can you build a cool tool? Are you particularly good with finance? Can you, you know, sit in on budgets? That kind of thing. So whatever additional pieces an aspiring MSL can add can really enhance fit. And sometimes in interviewing MSLs, I I look at those, and then I bring that back to the MSL leader and say, you know, this person, you know, they've got a and they present beautifully, but, you know, this thing about b makes them really interesting fit.
25:56I also remember when I was hiring one of my final roles for my operations team leaning towards somebody. We had a couple of good candidates, but one had a particular skill set that nobody else in the candidate pool had no. I'm sorry. Not in that nobody else in my existing team had. And that was, like, fit. Was like, okay. They're adding something, and it wasn't in the job description. Mhmm. But it was so useful from and from a fit perspective because they would they would make
26:27everybody on my team better. And and so that was, like, a fit bonus for me. And I think that's actually really good advice because I think a lot of people that are interviewing are trying to stand out. They're trying to figure out how do I become the person that ultimately gets this job. So think about that fit. How do you show that you're a fit? Well, you have to learn about the organization. You have to do well on the interview. You have to be inquisitive on the interview. You have to know about the the the players and the goals.
26:59Mhmm. So assess, like you said, how are you going to be valuable to that organization, and how can you show that you're a fit? So things are said then done. But Yeah. So just to bluntly interrupt there, be well rounded Yeah. Is is is always good advice. You know, we spend and AI and ATS tracking systems haven't done us any favors in this regard because we're trying to make ourselves fit the exact role that's published and be well
27:33rounded kinda contradicts that a little bit, but I still think it's good advice because you never know when that side talent or skill is going to be the thing that makes you stand out. It makes you human, which I think when it comes to interviewing and one on ones and establishing fit, the the human perspective is is the one thing that stands out above all. And getting back to the sausage being made and maybe some of the challenges and messiness of
28:04it, how do you make difficult personnel decisions? Not just not just, like, terminations and performance issues, but Mhmm. Also promotions Mhmm. And acknowledgments of Mhmm. A team member. Can you talk about that a little bit? I absolutely can. Because I think, at the introductory lower levels of medical affairs organizations, there isn't that level of transparency in how those decisions are made.
28:37And and so I do think a window into that is helpful. I think the most common process for promotions is a leadership team will get together and be asked if you have anybody on your team, who you think is deserving of a promotion, bring some supportive information to a meeting, and we'll talk about it. And that's where the, you know, the supervisor will get some open feedback on on that person.
29:09And, hopefully, if the promotion's going to happen, find out that that person is is supporting, and being an outstanding partner in delivering excellence, you know, to multiple stakeholders. It is not just about the supervisor employee relationship, and that stage is set well in advance of the performance review or the merit review, often by months. And so promotions just don't happen in a vacuum because somebody says yes. There's feedback involved. There's careful thought, not just about the person, but about the organization and about
29:41the role. And the best advice I can give somebody who wants a promotion and wants to influence the decision is to broaden the role and get the company dependent on a role whose behaviors and expectations are above what the what it actually is. Because if you're drawing an organization from scratch, you're not thinking about the people. You're developing the role, and you're deciding whether something is a senior director or a director or a manager, etcetera.
30:11There's a set of expectations about experience levels, about behaviors, about strategic thinking, etcetera, etcetera. If you can overdeliver in that role the company is now depending on it, then you've made the case essentially for a revision to the structure. And and that's the most effective way I've seen for title and associated salary and bonus increases is to be so good at your job, you've actually expanded the role and and made it critical to the company. So I think so that's about, you know, the good side of it.
30:43The bad side of it, obviously, if you're talking about termination of an employee, HR is involved, discussions, feedback, performance improvement plans. It's a very careful process, usually. It's not something we like to talk about, but most of us have have seen it happen. It's uncomfortable, but it's it's usually thought out. Mhmm. And it's usually carefully constructed. And in my extremely limited experience, it's been done compassionately.
31:17Good advice. And one thing I wanna point out is is is to be undeniable is basically what you're saying in in a nutshell. And I I I've talked about that a lot on this this podcast. When when you're so good, that it becomes so obvious to everyone involved that you're deserving of it, then that's when the promotions happen. But getting back to, the decision making process, what what's one unspoken truth that
31:54exists in pharma and biotech as it relates to this? Unspoken truth. The first one comes to mind is is what I just said around promotions that there's group input into an individual's performance beyond just the supervisor. The best, you know, performance reviews involve stakeholder feedback. Right? I think we we've all seen that. That's fairly standard, nowadays. Promotions go beyond that. You're you're actively soliciting examples where somebody's gone above and beyond and and
32:27has depended on it. I think, the unspoken truth, particularly as the decisions get complex, is how many meetings and how much time is spent talking through things, analyzing things. I've been fortunate that I can count on just a few fingers how many decisions from my limited perspective I thought were being made impulsively. Most decisions are the result of a great deal of forethought, a lot of time, a lot of people,
33:03a lot of care. Doesn't mean we always like the results. It doesn't mean we think the results are best for the function, but they're not impulsive. And so I think the unspoken truth is how much time is taken in pharma, and particularly because the stakes are so high. Because nobody wants to do something that is wrong by physicians and patients. The the decision making, in my experience, is very careful, and I think that's a great thing. Yeah. I I mean, I think that this is number one great advice, great insights, and it makes me wanna
33:39eat sausage. Like, I feel like I need to go have breakfast somewhere and get myself some, you know so I guess the the last question is links or patties for you. What do you go with? I will go with either. Now if so my wife is all about sausage patties, particularly on her pizza. She will if we're going to a new pizza place, she will, frankly, interrogate the waiter the the server and say, your sausage is the crumbly kind. She's very particular.
34:10I can go either way. I'm much more interested in the seasoning and and the flavor profile. I like I'm an equal opportunity. I like the good stuff. Myself. Yeah. Awesome. Well, Michael, thank you for your insights. Thanks for coming on. This was great. Really interesting conversation. We never really talked about this specifically as we have, you know, this whole decision making process. So thanks for shedding light. Thanks for coming on. Appreciate it. Pleasure. I really enjoyed it. I had fun. Good, man. Guys, as always, thank you for your support. Thank you for sharing this with friends.
34:43If you got value in this, please share it with others. And as I said before, and as Michael said, happy holidays to you all. Love you guys. We'll see you next time.